Clinical Trials

Morris Animal Foundation funds many ongoing clinical trials essential to advancing veterinary medicine and improving the health of animals today and tomorrow. These studies help veterinarians develop and improve new diagnostics, treatments and preventives for pet illnesses, as well as improve the quality of care patients receive.


The information below will help you determine if your pet may qualify to enroll in a study. For complete information on each clinical trial, contact the veterinary teaching hospital conducting the study or consult your veterinarian.


Degenerative Myelopathy Therapy

North Carolina State University (Study D19CA-033)
Evaluate a novel treatment aimed at silencing a genetic mutation associated with degenerative myelopathy, an incurable, progressive disease of the spinal cord.
Inclusion Criteria: Client-owned dogs with clinical signs of degenerative myelopathy and confirmed homozygous-affected mutation of the SOD1 gene.
Enrollment Site: North Carolina State University

Kidney Disease

North Carolina State University (Study ID: D12CA-053)
Find out why some dogs have poor therapeutic response to standard-of-care drugs and find new ways to optimize their therapy.
Inclusion criteria: Dogs diagnosed with proteinuria as a result of kidney disease primarily affecting the glomerulus and that is unlikely to be due to a concurrent disease outside the kidney.
Enrollment sites: North Carolina State University, Iowa State University, Ohio State University and Colorado State University


Genetic Impact on Heart Drug Therapy

The University of California, Davis (Study ID: D18FE-014)
Determine if genetic mutations are linked to how well or how poorly a cat with heart disease responds to clopidogrel, a blood thinner used to prevent life-threatening blood clot complications. Findings may help facilitate personalized medicine decisions and improve outcomes for these patients.
Inclusion criteria: Client-owned cats diagnosed with the heart condition, hypertrophic cardiomyopathy.
Enrollment sites: University of California, Davis

Anti-Clotting Drugs and Heart Disease

The University of Georgia (Study ID: D16FE-015)
Compare the efficacy of two drugs for preventing recurrent thromboembolism (blood clots) in cats that have experienced and recovered from a prior clot event due to heart disease.
Inclusion criteria: Client-owned cats that have been diagnosed with a thromboembolism due to cardiac disease.
Enrollment sites: Any veterinarian can enroll a cat, but examination by a board-certified veterinary cardiologist is required for inclusion in the study.



The University of Georgia (Study ID: D17EQ-304)
Determine how long infected horses shed Salmonella in their feces and use this new information to improve infection prevention and control.
Inclusion criteria: Horses that are shedding Salmonella (clinically or sub-clinically affected).
Enrollment sites: Throughout the United States and Canada; sample collections kits and instructions provided.

For More Clinical Trials

Visit the searchable clinical trials database at the AVMA Health Studies Database for a comprehensive list of pet clinical trials in the United States and Canada, including Morris Animal Foundation-funded clinical trials.

Be The First to Know

Be the first to hear about breakthroughs that help pets and wildlife have healthier, longer lives.